| Study name |
Levetiracetam used as first‐line anti‐epileptic versus phenobarbitone in neonatal convulsions |
| Methods |
RCT, add‐on if required |
| Participants |
Neonates with clinical seizures |
| Interventions |
LEV 20‐40 mg/kg, maintenance vs PB 20‐30 mg/kg, maintenance |
| Outcomes |
Cessation of seizures, recurrence at 24 hours, need for further ASM, adverse events, absence of seizures at 48 hours, adverse events |
| Starting date |
2014 |
| Contact information |
zyee08@gmail.com |
| Notes |
Sample size 100, achieved, reported that LEV more efficient than PB; no PubMed listing |
